Galectin Therapeutics
GALT
$3.23
Share price
2.87%
Change (1 day)
93.41%
Change (1 year)
Categories
Galectin Therapeutics (GALT) - Total debt
Total debt on the balance sheet as of December 2023 : $71.78 M
According to Galectin Therapeutics's latest financial reports the company's total debt is $71.78 M. A company’s total debt is the sum of all current and non-current debts.
Galectin Therapeutics - Total debt on balance sheet (from 2001 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $39.86 M | 37.21% |
| 2021-12-31 | $29.05 M | 65936.36% |
| 2020-12-31 | $0.04 M | 12.82% |
| 2019-12-31 | $0.03 M | |
| 2018-12-31 | $N/A | |
| 2009-12-31 | $N/A | -100% |
| 2008-12-31 | $0.2 M | |
| 2002-12-31 | $0.01 M | -92.31% |
| 2001-12-31 | $0.19 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Mirati Therapeutics MRTX | $50.22 M | -30.04% | 🇺🇸 USA |
 MannKind Corp MNKD | $0.27 B | 279.77% | 🇺🇸 USA |